Kuhn JG - Search Results

1

Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibiotic.

Dorr FA, Von Hoff DD, Kuhn JG, Schwartz R, Kisner DL. Dorr FA, et al. Among authors: kuhn jg. Cancer Res. 1986 May;46(5):2562-5. Cancer Res. 1986. PMID: 2938729

2

Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite.

Hutton JJ, Von Hoff DD, Kuhn J, Phillips J, Hersh M, Clark G. Hutton JJ, et al. Cancer Res. 1984 Sep;44(9):4183-6. Cancer Res. 1984. PMID: 6204752

3

Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.

Von Hoff DD, Pollard E, Kuhn J, Murray E, Coltman CA Jr. Von Hoff DD, et al. Cancer Res. 1980 May;40(5):1516-8. Cancer Res. 1980. PMID: 7370989

4

Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors.

Sarosy GA, Brown TD, Von Hoff DD, Spiegel RJ, Golando JP, Beougher KL, Kuhn JG, Kisner DL. Sarosy GA, et al. Among authors: kuhn jg. Cancer Res. 1986 Oct;46(10):5368-71. Cancer Res. 1986. PMID: 3756887

5

Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942).

Von Hoff DD, Myers JW, Kuhn J, Sandbach JF, Pocelinko R, Clark G, Coltman CA Jr. Von Hoff DD, et al. Cancer Res. 1981 Aug;41(8):3118-21. Cancer Res. 1981. PMID: 6265075

6

Phase I investigation of ametantrone.

Loesch DM, Von Hoff DD, Kuhn J, Coltman CA, Tio F, Chaudhuri TK, Bender JF, Grillo-Lopez AJ. Loesch DM, et al. Cancer Treat Rep. 1983 Nov;67(11):987-91. Cancer Treat Rep. 1983. PMID: 6640557

7

Does color of an antitumor agent predict for clinical antitumor activity?

Von Hoff DD, Kuhn J, Clark G. Von Hoff DD, et al. Cancer Chemother Pharmacol. 1981;6(1):93-4. doi: 10.1007/BF00253016. Cancer Chemother Pharmacol. 1981. PMID: 7273269 No abstract available.

8

Phase I clinical and pharmacokinetic trial of flavone acetic acid.

Havlin KA, Kuhn JG, Craig JB, Boldt DH, Weiss GR, Koeller J, Harman G, Schwartz R, Clark GN, Von Hoff DD. Havlin KA, et al. Among authors: kuhn jg. J Natl Cancer Inst. 1991 Jan 16;83(2):124-8. doi: 10.1093/jnci/83.2.124. J Natl Cancer Inst. 1991. PMID: 1703237 Clinical Trial.

9

A phase I clinical and pharmacokinetic trial of hepsulfam.

Ravdin PM, Havlin KA, Marshall MV, Brown TD, Koeller JM, Kuhn JG, Rodriguez G, Von Hoff DD. Ravdin PM, et al. Among authors: kuhn jg. Cancer Res. 1991 Dec 1;51(23 Pt 1):6268-72. Cancer Res. 1991. PMID: 1933887 Clinical Trial.

10

Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule.

Von Hoff DD, Kuhn JG, Havlin KA, Langevin AM, Brown TD, Weiss GR, Turner JN, Purvis J, Lucas VS, Bair KW, et al. Von Hoff DD, et al. Among authors: kuhn jg. Cancer Res. 1990 Dec 1;50(23):7496-500. Cancer Res. 1990. PMID: 2253197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters